For instance, the study reported by Barnes et al. highlighted that the ‘at risk’ G/G genotype of the IL-6 gene was associated with a higher severity of somatic symptoms of depression in patients undergoing interferon-alpha (IFN-α) treatment [103]. The gene discussed is IL6; the disease is major depressive disorder.